Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. (Q53660703)

17 May 2018

title

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. (English)

1 reference

17 May 2018

0 references

0 references

4

1 reference

17 May 2018

author name string

Naveed Younis

1

1 reference

17 May 2018

Deborah M Broadbent

2

1 reference

17 May 2018

Jiten P Vora

3

1 reference

17 May 2018

Liverpool Diabetic Eye Study

5

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 January 2003

1 reference

17 May 2018

published in

The Lancet

1 reference

17 May 2018

volume

361

1 reference

17 May 2018

issue

9353

1 reference

17 May 2018

page(s)

195-200

1 reference

17 May 2018

Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Visual impairment in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Preservation of sight in diabetes: developing a national risk reduction programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Screening for eye disease in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Progression of retinopathy is related to glycaemic control even in patients with mild diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Cost effectiveness analysis of screening for sight threatening diabetic eye disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Incidence of Diabetic Retinopathy and Relationship to Baseline Plasma Glucose and Blood Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycaemic agents and diet regime alone. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

Mobile retinal screening in Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912267-2

7 January 2021

10.1016/S0140-6736(03)12267-2

Identifiers

DOI

1 reference

17 May 2018

PubMed ID

12547541

1 reference

17 May 2018